Procept BioRobotics price target lowered to $30 from $47 at Truist

Truist lowered the firm’s price target connected Procept BioRobotics (PRCT) to $30 from $47 but keeps a Buy standing connected the shares. The company’s Q4 missed estimates, though its Analyst Day laid retired a lawsuit for sustainable maturation of 25% oregon much done 2027, highlighted by ongoing penetration into the BPH opportunity, strategy changes geared towards expanding utilization and much visibility into the business, the expert tells investors successful a probe note.

Claim 70% Off TipRanks Premium

• Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions

• Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See today’s best-performing stocks connected TipRanks >>

Read More connected PRCT:

Disclaimer & DisclosureReport an Issue

• Procept BioRobotics terms people lowered to $34 from $50 astatine TD Cowen

• Procept BioRobotics terms people lowered to $28 from $50 astatine Piper Sandler

• PROCEPT BioRobotics Highlights Growth Strategy astatine Investor Day

• Procept BioRobotics sees FY26 gross maturation 27%-33%

• Procept BioRobotics downgraded to Perform from Outperform astatine Oppenheimer